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Abstract
Background: The trophoblast compartment of the placenta comprises various subpopulations with distinct functions. They
interact among each other by secreted signals thus forming autocrine or paracrine regulatory loops. We established a first
trimester trophoblast cell line (ACH-3P) by fusion of primary human first trimester trophoblasts (week 12 of gestation) with a
human choriocarcinoma cell line (AC1-1).
Results: Expression of trophoblast markers (cytokeratin-7, integrins, matrix metalloproteinases), invasion abilities and
transcriptome of ACH-3P closely resembled primary trophoblasts. Morphology, cytogenetics and doubling time was similar to
the parental AC1-1 cells. The different subpopulations of trophoblasts e.g., villous and extravillous trophoblasts also exist in
ACH-3P cells and can be immuno-separated by HLA-G surface expression. HLA-G positive ACH-3P display pseudopodia and a
stronger expression of extravillous trophoblast markers. Higher expression of insulin-like growth factor II receptor and human
chorionic gonadotropin represents the basis for the known autocrine stimulation of extravillous trophoblasts.
Conclusion: We conclude that ACH-3P represent a tool to investigate interaction of syngeneic trophoblast subpopulations.
These cells are particularly suited for studies into autocrine and paracrine regulation of various aspects of trophoblast function.
As an example a novel effect of TNF-α on matrix metalloproteinase 15 in HLA-G positive ACH-3P and explants was found.
Published: 19 December 2007
BMC Developmental Biology 2007, 7:137 doi:10.1186/1471-213X-7-137
Received: 20 June 2007
Accepted: 19 December 2007
This article is available from: http://www.biomedcentral.com/1471-213X/7/137
© 2007 Hiden and Wadsack; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 13
(page number not for citation purposes)
BMC Developmental Biology 2007, 7:137 http://www.biomedcentral.com/1471-213X/7/137Background
In the first trimester of pregnancy the placental trophob-
last has to fulfil a wide range of key functions in order to
establish and maintain a successful pregnancy. These are
not covered by one trophoblast phenotype, but rather
associated with various trophoblast subpopulations each
with unique features. In a series of differentiation steps
the trophoblast subpopulations originate from cytotro-
phoblast stem cells [1], and acquire specific functions
associated with their distinct tasks. Two main differentia-
tion pathways of cytotrophoblasts are known: 1) in the
villous pathway they differentiate and fuse to form the
syncytiotrophoblast. This differentiation is paralleled by
the onset of secretion of β-human chorionic gonadotro-
pin (β-hCG). In the extravillous pathway they differenti-
ate into the extravillous cytotrophoblast (EVT). A small
subgroup of these cells maintains their proliferative capac-
ity, while most of the cells further differentiate into highly
invasive extravillous trophoblasts that invade the mater-
nal uterine wall thereby ultimately opening the uterine
spiral arteries.
Proper invasion is critical for placental and fetal develop-
ment and its dysregulation results in a considerable spec-
trum of pregnancy abnormalities. Shallow invasion has
been implicated in intra-uterine growth restriction
(IUGR) [2,3] and early-onset pre-eclampsia [4-7]. In con-
trast, profuse invasion results in abnormally deep utero-
placental adhesion such as seen in placenta accreta,
increta and percreta, or may even lead to placental-site
tumors [8]. The process of physiological invasion is tightly
regulated in space and time by invasion-promoting and
invasion-inhibiting factors that bind to receptors
expressed on the extravillous trophoblasts. The invasion
regulating factors either originate from the maternal
decidua, the villous stroma or are secreted by various tro-
phoblast populations. Decidua-derived soluble factors,
such as transforming growth factor beta (TGFβ), tissue
inhibitor of metalloproteinases-1 (TIMP-1) and kisspep-
tin-10 decrease trophoblast invasion, whereas insulin-like
growth factor-I (IGF1) and-II (IGF2), β-hCG, endothelin-
1 (EDN1), epidermal growth factor (EGF) and hepatocyte
growth factor (HGF), all of them highly expressed in the
placenta of the first trimester, stimulate trophoblast inva-
sion [9-19]. TNF-α is a cytokine produced and secreted by
trophoblasts and decidual macrophages that limits tro-
phoblast invasion as well as the trophoblast-endothelial
interaction in the uterine spiral arteries . Cytokines and
growth factors secreted by cells in the decidua or the tro-
phoblast thus form autocrine or paracrine loops ulti-
mately fine-tuning the regulation of trophoblast invasion
in a concerted manner.
In vitro research into the regulation of this physiological,
non-malignant invasion is not only hampered by the lim-
ited availability of first trimester placental tissue, but also
by the limited lifespan of primary first trimester trophob-
lasts in culture as they differentiate and shift into stages of
apoptosis . In order to overcome this problem a number
of human choriocarcinoma cell lines have been estab-
lished such as BeWo, JAR and JEG3 that display a long
lifespan and high proliferation activity. However, these
cells reflect a carcinogenic cell type and differ from pri-
mary trophoblasts in many regards. Choriocarcinoma
cells are malignant, immortal cells exhibiting non-physio-
logical carcinogenesis  and they have developed mecha-
nisms enabling them to escape from control of normal
trophoblast invasion  i.e., from decidual cytokines  or low
oxygen . Thus, choriocarcinoma cell lines have to be con-
sidered critically as cell model for trophoblast invasion.
Several trophoblast cell lines have been established and
characterized. All of them have different features and each
of them may resemble a distinct trophoblast subpopula-
tion. They are important for investigations on the specific
trophoblast subpopulations. However, they are of limited
value for studies into the paracrine/autocrine interplay
between subpopulations of trophoblasts a) as they do not
comprise the subpopulations, b) because of their differing
genetic background, and c) because of the varying strate-
gies used for their immortalization. Since the interaction
between subpopulations is a fine-tuned mechanism even
subtle differences in genetic background may play an
important role.
In order to overcome these limitations we have designed
a strategy allowing to establish an immortal first trimester
cell line (ACH-3P). Immortalization was achieved by fus-
ing primary first trimester trophoblast cells with the chor-
iocarcinoma cell line AC1-1 .
First trimester trophoblasts isolated from human placen-
tas essentially comprise two trophoblast subpopulations,
villous cytotrophoblasts (VCT) and invasive extravillous
trophoblasts . Both populations differ among other fea-
tures in their expression of HLA-G. We hypothesized the
presence of these subpopulations also in the hybrid cells.
Different from all other cell lines they will have a syn-
geneic background.
After their development and rigorous characterization the
ACH-3P cells were used to identify autocrine and para-
crine loops related to trophoblast invasion and differenti-
ation. Thereby, a novel TNF-α effect on the expression of
the membrane bound matrix metalloproteinase MMP15
(MT2-MMP) was discovered. MMP15 is mainly expressed
by extravillous trophoblasts, cleaves components of the
extracellular matrix and activates various pro-proteins
present in the extracellular space i.e., proMMP2 and pro-
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Morphology and cell culture
ACH-3P showed a uniform polygonal, epithelial-like
cytomorphology (Fig. 1A) similar to the parental cell line
AC1-1. The mean diameter and the volume of the cells
were greater in both cell lines AC1-1 and ACH-3P than in
primary trophoblasts (Table 1).
The generation time in ACH-3P was shorter than in AC1-
1, hence, ACH-3P, like AC1-1, represents a strongly prolif-
erating cell line (Table 2). Most preparations of primary
trophoblasts hardly proliferate under the conditions used
and were, therefore, not included into this comparison.
Expression of trophoblast markers
Immunocytochemistry and FACS analysis of ACH-3P
(Table 1) demonstrated a stable expression of the tro-
phoblast marker cytokeratin-7, but absence of vimentin, a
protein, that is present in all non-trophoblast cells. This is
a clear demonstration of the trophoblast origin of ACH-
3P (Fig. 1B).
ACH-3P secreted hCG, a hormone expressed by differen-
tiated cytotrophoblasts and the syncytiotrophoblast, but
accumulated over 24 hours higher in AC1-1 and highest
in first trimester trophoblasts (Table 3). According to gel-
atin gel zymography ACH-3P produce the invasion rele-
vant active matrix-metalloproteinases MMP2 and MMP9
similar to primary trophoblasts, whereas in the culture
supernatant of AC1-1 a very high amount of only MMP2
was detected (Fig. 1C).
According to FACS analysis ACH-3P cells are heterogene-
ous for the non-classical MHC antigen HLA-G, a protein
characteristic for highly invasive EVT. About 60% of the
cells were HLA-G negative and 40% showed moderate
HLA-G expression (Fig. 1D). This heterogeneity was also
found in first trimester primary trophoblasts, but with a
smaller number (12%) of HLA-G positive cells. In con-
trast AC1-1 cells strongly express HLA-G. According to
propidium iodide (PI) staining after methanol fixation
the HLA-G positive and negative population within the
ACH-3P cells did not differ in DNA amount (data not
shown).
Invasion ability
In invasion assays primary trophoblasts and ACH-3P
revealed the highest invasion index on laminin and the
lowest on collagen-1 (Fig. 2). A different pattern was
observed with the highly invasive AC1-1. Here, invasion
was strongest on fibronectin and weakest on Matrigel.
Cytogenetic analysis
Fifty metaphases were cytogenetically analysed (Fig. 3).
Fusion of AC1-1 cells that contain 60–69 chromosomes
with primary trophoblasts resulted in ACH-3P cells. They
contain 94–98 chromosomes and represent a male cell
line like their parental cell line AC1-1.
Table 1: Cellular size distribution and generation time of first 
trimester primary trophoblasts, ACH-3P and AC1-1 obtained by 
CASY®.
FT ACH-3P AC1-1
mean diameter [μm] 15.5 ± 1.2 23.5 ± 1.0 22.9 ± 0.7
mean volume [μl] 2.6 ± 0.57 8.8 ± 1.01 8.1 ± 1.09
generation time [h] -- 14.8 ± 1.48 18.0 ± 1.85
Morphology and trophoblast marker expression of parental fusion partners and hybrid cellsFigure 1
Morphology and trophoblast marker expression of 
parental fusion partners and hybrid cells. The photomi-
crographs representative shows cultured first trimester tro-
phoblasts (FT) 48 hours after isolation, ACH-3P hybrid cells 
and AC1-1 choriocarcinoma cells, both in the 6th passage 
(20 × magnification) (A). IHC staining for cytokeratin-7 and 
vimentin of ACH-3P (B). Representative zymography of cell 
culture supernatants from FT, ACH-3P and AC1-1 after 48 h 
culture indicating presence of MMP9 and MMP2 (C). Repre-
sentative FACS analysis for HLA-G (thick line) on viable 
ACH-3P cells (D). The result of the control antibody is 
shown (thin line) as overlay.Page 3 of 13
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A heatmap displays all genes that were differentially
expressed (832 genes with a fold change > 2) between
these cells (Fig. 4). The dendrogram at the top indicates
the close relationship between ACH-3P and first trimester
primary trophoblast cells and the larger distance to the
AC1-1 cells. Thus, the transcriptome of the fused ACH-3P
closely resembles that of the parental primary first trimes-
ter trophoblasts.
When the genes differentially expressed between the
ACH-3P and primary trophoblasts were clustered accord-
ing to their putative function, a predominant proportion
was related to cell cycle regulation, oncogenesis and pro-
liferation. The full list as well as a functional categoriza-
tion into most prominent biological processes of these
genes is given in the additional tables [1 and 2]. The carci-
noma cells AC1-1 differ by more than 800 genes from the
ACH3P and the primary trophoblasts [see figure 1].
Characteristics of the HLA-G positive and negative ACH-
3P and primary trophoblast subpopulations
Immuno-separation of the HLA-G positive and negative
ACH-3P cells resulted in morphologically different cell
populations (Fig. 5). More (p > 0.001) HLA-G positive
than negative cells (1.3 vs. 0.05) showed a higher number
of pseudopodia. RT-PCR found EVT-specific genes
expressed at higher levels in the HLA-G positive subpopu-
Table 2: Primer pairs designed for semiquantitative RT-PCR. The number of PCR cycles is indicated for ACH-3P cells and first 
trimester trophoblasts.
Gene RefSeq Primer Cycle No
RPL30 NM_000989 for: CCT AAG GCA GGA AGA TGG TG
rev: CAG TCT GTT CTG GCA TGC TT
ACH-3P: 20
FT: 25
HLAG NM_002127 for: AGG AGA CAC GGA ACA CCA AG
rev: CCT CCA GGT AGG CTC TCC TT
ACH-3P: 25
FT: 27
ITGA1 NM_181501 for: GTC CAG TTG GGA GAG GTG AA
rev: TGA ATG CCT CCT TTC TTG CT
ACH-3P: 26
ITGA5 NM_002205 for: TCC TGG AGT CCT CAC TGT CC
rev: TCC TTG GCA GTA ACC CTG TC
ACH-3P: 23
ITGA6 NM_000210 for: GGC GGT GTT ATG TCC TGA GT
rev: CAT GCT CAG TCT CTC CAC CA
ACH-3P: 25
MMP2 NM_004530 for: TTG GCA GTG CAA TAC CTG AA
rev: GAG CAA AGG CAT CAT CCA CT
ACH-3P: 20
MMP9 NM_004994 for: GAG ACC GGT GAG CTG GAT AG
rev: CAC CAA ACT GGA TGA CGA TG
ACH-3P: 35
MMP14 NM_004995 for: AAG GCA CAC TTG CTC CTG TT
rev: CAC TGG TGA GAC AGG CTT GA
ACH-3P: 23
FT: 25
MMP15 NM_002428 for: GGC CGA CAT CAT GGT ACT CT
rev: GTC AAC GTC CTT CCA CTG GT
ACH-3P: 24
FT: 26
EDN1 NM_001955 for: CTC GTC CCT GAT GGA TAA A
rev: TCC TGC TTG GCA AAA ATT C
ACH-3P: 35
FT: 35
EDNRA NM_001957 for: ATC ACC GTC CTC AAC CTC TG
rev: CCA ATT CCC TGA ACA CGA CT
ACH-3P: 35
FT: 35
EDNRB NM_000115 for: ATC TGC GAA TCT GCT TGC TT
rev: AGC CAC CAA TCT TTT GCT GT
ACH-3P: 33
FT: 35
β-hCG NM_000737 for: GTC AAC ACC ACC ATC TGT GC
rev: GGC CTT TGA GGA AGA GGA GT
ACH-3P: 24
IGF1 NM000618 for: TGG ATG CTC TTC AGT TCG TG
rev: CCT GCA CTC CCT CTA CTT GC
ACH-3P: 35
FT: 35
IGF2 NM_000612 for: GGT GCT TCT CAC CTT CTT GG
rev: GGG GTA TCT GGG GAA GTT GT
ACH-3P: 25
FT: 25
IGF1R NM_000875 for: GGA TGC GGT GTC CAA TAA CT
rev: TGG CAG CAC TCA TTG TTC TC
ACH-3P: 29
FT: 32
IGF2R NM_00876 for: TGA GTA TGC CTG CCA CAG AG
rev: TCA AGG TGA GGT CTC CAT CC
ACH-3P: 26
FT: 29
INSR NM_000208 for: GAG TCC TCG TTT AGG AAG ACG
rev: AAG TGT TGG GGA AAG CTG CCA
ACH-3P: 31
FT: 33
TNFA NM_000594 for: GAC AAG CCT GTA GCC CAT GT
rev: TTG ATG GCA GAG AGG AGG TT
ACH-3P: 33
FT: 33
TNFR1 NM_001065 for: ACC AAG TGC CAC AAA GGA AC
rev: CTG CAA TTG AAG CAC TGG AA
ACH-3P: 25
FT: 27
TNFR2 NM_001165 for: CCA AGT GGT TTC CAA GGT GT
rev: CAC GGC AGC ATT AAT CAC AG
ACH-3P: 29
FT: 31Page 4 of 13
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but also other MMPs (MMP15), a pro-invasive acting
receptor (IGF2R) of which β-hCG modulates the affinity.
The expression of ITGA1 and ITGA6 between the HLA-G
positive and negative ACH-3P subpopulations did not
correlate with the expression pattern of HLA-G positive
and negative primary cells. This degeneration is obviously
a remnant of the parental AC1-1 cells and a common
result of carcinogenesis (Table 4). No change was found in
the expression of the endothelin and IGF1 receptor-ligand
systems (EDN1; EDNRA; EDNRB; IGF1; IGF2; IGF1R).
The difference in gene expression levels between HLA-G
expressing and lacking ACH-3P resembled the HLA-G
positive and negative subpopulations of the primary tro-
phoblasts. MMP15 and IGF2R were higher expressed also
in their HLA-G positive ACH-P and trophoblast subpopu-
lation whereas the TNFR2 mRNA level was considerably
higher in the HLA-G negative subpopulations of cell line
(3.5 ± 0.4) and primary cells (1.3 ± 0.18). The difference
in expression of the investigated genes remained stable in
the two ACH-3P subpopulations up to passage 5 after sep-
aration after which time these decline.
Effect of TNF-α on MMP15 expression in HLA-G positive 
and negative ACH-3P cells and in first trimester placental 
explants
TNF-α treatment increased the expression of MMP15 only
in the HLA-G positive ACH-3P cells and in first trimester
placental explants (Fig. 6). The oxygen tension (3% O2)
used for the explant culture mimics the in vitro situation in
a 7th week of gestation. As EVT are the cell type predomi-
nantly expressing MT2-MMP , the MT2-MMP in the
explant is presumed to be expressed by the EVT.
Discussion
ACH-3P closely resemble first trimester trophoblasts
The new hybrid cell line ACH-3P strongly expresses cytok-
eratin-7, but is devoid of vimentin, a protein expressed in
all non-trophoblast cells of the placenta proper . Hence,
ACH-3P is a trophoblast cell line. In addition to this
standard criterion, the expression pattern of well estab-
lished proteins [1] typical for different first trimester tro-
phoblast subpopulations (Table 4) demonstrates that
ACH-3P cells express various markers for invading EVT
i.e., HLA-G , integrin α5β1  and the gelatinases MMP2 and
MMP9 . In addition, the presence of markers typical for
Representative karyotype of ACH-3P cellsFigure 3
Representative karyotype of ACH-3P cells. Chromo-
somes given in the bottom row could not be assigned.
Table 3: Expression of trophoblast markers and markers for 
trophoblast subpopulations in primary first trimester 
trophoblasts, ACH-3P and AC1-1. The expression of the 
trophoblast marker cytokeratin-7 (CK7) was determined by 
immunocytochemistry and of markers for trophoblast subtypes 
(HLA-G, integrins) were detected by FACS analysis. Secretion of 
hCG was measured after 24 hours in the culture supernatant and 
normalized to the cell number. The activity of MMP2 and MMP9 
was measured by gelatin gel zymography. + indicates ~20–40% of 
cells. ++ indicates ~40–90%; +++ indicates 100% of cells; – 
indicates no expression.
FT ACH-3P AC1-1
CK7 +++ +++ +++
Vimentin - - -
HLA-G ++/- ++/- ++
integrin α6 + ++ +
integrin β4 + ++ ++
integrin α5β1 +/- ++ ++
integrin α1 +/- - -
hCG +++ + +
MMP2 ++ + +
MMP9 + + +++
Comparison of invasion indices of parental fusion partners and hybrid cellsFigure 2
Comparison of invasion indices of parental fusion 
partners and hybrid cells. Invasion indices (mean ± SD, n 
= 3) of first trimester trophoblasts (FT), ACH-3P and AC1-1 
after 48 h in the presence of 10% FCS on different extracellu-
lar matrices.Page 5 of 13
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villous syncytiotrophoblast (hCG) in ACH-3P cells obvi-
ously reflects the heterogeneous pool of trophoblast sub-
populations in the preparations of primary first trimester
trophoblast cells (Table 4). As the ACH-3P comprise a
polyclonal cell line, the presence of other subpopulations
in addition to the described HLA-G positive and negative
cannot be excluded, but these may only occur to a low
proportion. After their separation, the subpopulations
remain stable up to the 5th passage. Therefore, it is man-
datory to always freshly isolate the target subpopulation
from the polyclonal pool for each experiment.
In addition to the presence of the characteristic EVT mark-
ers, ACH-3P were also capable of invading extracellular
matrices. The invasion indices on the different matrices
resembled that of first trimester trophoblasts with highest
values on laminin, which is paralleled by a strong expres-
sion of the laminin receptor integrin α6. Hence, ACH-3P
contain a subpopulation of cells with an EVT phenotype.
Contrary to the invasion properties and the expression of
trophoblast markers, the morphology, cellular size and
proliferation of ACH-3P resembled that of the parental
choriocarcinoma cell line AC1-1, a favourable result as
proliferation is a desired property of a model cell line.
Cytogenetic analysis revealed a high number of chromo-
somes. This was expected due to the fusion of a normal
somatic cell type with a tumour cell line that per se con-
tains 60–69 chromosomes. The range of 94 to 98 chromo-
somes and the stable DNA content of ACH-3P observed in
FACS analyses proved homogeneity with regard to chro-
mosome number and thus the consistent fusion of the
hybrid cells.
Photomicrograph of HLA-G positive (A) and HLA-G negative (B) subpopulation f ACH-3P cellsFigure 5
Photomicrograph of HLA-G positive (A) and HLA-G 
negative (B) subpopulation of ACH-3P cells. Cells are 
shown in the 3rd passage after immuno-separation (20 × 
magnification). Please note the presence of pseudopodia 
(indicated with arrows) in the HLA-G expressing (A) but not 
in the HLA-G negative cells. The number of pseudopodia per 
cell is shown in C. 200 cells of the outermost cells within the 
clusters were counted. *p > 0.001
Heatmap analysis of microarray data showing hierarchical clus ering of 832 di ferenti lly expres ed ge es between first trim ster primary trophoblasts, AC1-1 and ACH-3P cellsFigure 4
Heatmap analysis of microarray data showing hierar-
chical clustering of 832 differentially expressed genes 
between first trimester primary trophoblasts, AC1-1 
and ACH-3P cells. Three first trimester primary trophob-
last preparations (FT 1, 2, 3), two AC1-1 (AC1-1 1, 2) and 
two ACH-3P (ACH-3P 1, 2) RNA preparations were ana-
lyzed. Red or green colours indicate differentially up- or 
downregulated (619) genes, respectively (FC > 2 fold). The 
dendrogram displayed on top was based on hierarchical clus-
tering of the samples using the average linkage method indi-
cating the strong relation of the ACH3P cell line with the 
primary cells.Page 6 of 13
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TNF-α treatment (10 ng/ml) increased MMP15 mRNA expression in the HLA-G positive ACH-3P cells and in first trim ste  placenta explantsFigure 6
TNF-α treatment (10 ng/ml) increased MMP15 
mRNA expression in the HLA-G positive ACH-3P 
cells and in first trimester placenta explants. Please 
note that the oxygen conditions for cell culture and explant 
culture are different. Data (mean ± SD of n = 4 experiments) 
are expressed relative to the untreated controls (= 100%). 
Data shown were normalized to the controls whereas the 
statistic tests used the raw data. *p < 0.05 vs. control
Table 4: Expression of markers for trophoblast subpopulations and i
HLA-G negative ACH-3P, and in HLA-G positive versus HLA-G neg
measured by RT-PCR. The fold change values refer to the HLA-G n
genes in EVT versus VCT are indicated with arrows and according 
preparations only genes with differential expression between the AC
expressed between the HLA-G positive and HLA-G negative cells in
(mean ± SD of n = 4 experiments). NC: no change
ACH-3P
fold change HLA-G + vs. HLA-G
HLA-G 20 ± 0.50
ITGA1 NC
ITGA5 1.2 ± 0.10
ITGA6 NC
MMP2 3.9 ± 0.50
MMP9 5.3 ± 0.70
MMP15 3.0 ± 0.40
β-hCG 4.4 ± 0.20
IGF2 NC
IGF2R 1.2 ± 0.10
TNFA NC
TNFR1 NC
TNFR2 -1.3 ± 0.18Microarray analysis paralleled the above observed close
relationship between first trimester primary trophoblasts
and ACH-3P. This was clearly seen by the hierarchical
clustering of all genes differently expressed between ACH-
3P and first trimester primary trophoblasts as well as
between first trimester primary trophoblasts and AC1-1.
Autocrine/paracrine regulation of invasion relevant 
molecules of ACH-3P subpopulations
After immuno-separation for HLA-G the two subpopula-
tions differed in their morphology and in the expression
of a number of invasion relevant genes. The HLA-G posi-
tive cells impress by their high number of pseudopodia,
extensions of the plasma membrane that enable invasion
of motile cells. This obviously reflects the high invasion
capacity of the HLA-G positive ACH-3P subpopulations.
Additionally, these cells exhibited a higher expression of
various markers of the invasive EVT lineage such as
integrin α5, MMPs (i.e. MMP2, MMP9, and MMP15) and
hCG. This strongly resembled the HLA-G positive first tri-
mester trophoblasts indicating that the phenotype of the
trophoblast subpopulations remained in the fused cells
(Fig. 7).
This notion is substantiated further by the prevailing pres-
ence of components forming an established autocrine
loop to regulate invasion in the HLA-G positive primary
trophoblasts and ACH-3P cells. Beta-hCG is known to
stimulate invasion by modulating IGF2 binding to the
IGF-2R on [12]. The higher expression of both modulator
and receptor in the HLA-G positive EVT was confirmed in
our primary trophoblast preparations. It was also found in
nvasion relevant ligand-receptor systems in HLA-G positive versus 
ative primary trophoblasts (i.e. EVT vs. VCT). Expression was 
egative cells (= 1). Direction of expression changes of well studied 
to literature. Because of the low yield of primary trophoblast 
H-3P subpopulations were investigated. Genes that are differently 
 primary trophoblasts and in the ACH-3P cells are printed in bold. 
FT
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BMC Developmental Biology 2007, 7:137 http://www.biomedcentral.com/1471-213X/7/137the ACH-3P cells (Table 4; lower panel). This demon-
strates that the hybrid cells are well-suited for studies into
the regulation of components making up autocrine or
paracrine loops.
These features of ACH-3P cells were then used to test the
hypothesis that TNF-α, presumably derived from the
decidual macrophages or trophoblasts, will stimulate
MMP15 expression on invading i.e., HLA-G positive EVT.
If confirmed this would identify a novel effect of TNF-α
and establish a new heterologous paracrine or autocrine
regulation of one factor involved in trophoblast action
(Fig. 7). MMP15 is stronger expressed in the HLA-G posi-
tive primary cells (350%) and ACH-3P (30%), respec-
tively, and TNF-α is produced by cells located nearby the
invading trophoblasts i.e., the decidual macrophages.
This suggests a direct interaction and regulatory loop
between TNF-α and MMP15 expression. Furthermore,
MMP15 was up-regulated by TNF-α only in the invasive
HLA-G positive subpopulations of ACH-3P although the
expression of TNFR2 was higher in the HLA-G negative
subpopulations of the cell line and the primary cells. The
stronger responsiveness of MMP15 expression towards
TNF-α in the HLA-G positive cells despite their lower
TNFR2 expression is most likely a result of their higher
basal MMP15 expression level. The up-regulation was also
found in first trimester placental explants, an experimen-
tal model close to the in vivo situation. These findings
highlight that the induction of MMP15 expression is a
physiological effect and not only a result of the specific
conditions of cell culture. Because the different experi-
mental models i.e., ACH-3P cell culture and placental
explants, showed a similar response (Fig. 6), the effect of
TNF-α on MMP15 expression is obviously independent of
oxygen concentration and extracellular matrix. Impor-
tantly, again the model cells resembled the original tissue.
The consequences of these results for invasion regulation
are unclear, because in vitro TNF-α limits trophoblast inva-
sion. Nevertheless, MMP15 may not only be involved in
processes related to invasion, but as a result of its wide
spectrum of substrates, also in activation of pro-proteins
such as proMMP2 and proTNF-α. The newly identified
induction of MMP15 expression by TNF-α thus further
supports a key role of TNF-α in regulation of trophoblasts.
Conclusion
Collectively, the new ACH-3P cell line provides the char-
acteristics of different aspects of first trimester trophoblast
subtypes combined with the proliferation potential of the
parental choriocarcinoma cell line. It therefore, represents
a useful tool for the investigation of characteristic features
of first trimester trophoblasts such as non malignant inva-
sion. Furthermore, two subpopulations can be separated
according to HLA-G expression. The HLA-G positive cells
strongly resemble the invasive EVT and thus represent a
tool to investigate trophoblast invasion against the syn-
geneic HLA-G negative background. These cells are partic-
ularly well-suited for studies into autocrine and paracrine
Comparison between HLA-G negative and positive trophoblasts as well as HLA-G negative and positive ACH-3P subpopula-ti nsFigure 7
Comparison between HLA-G negative and positive trophoblasts as well as HLA-G negative and positive ACH-
3P subpopulations. Both HLA-G positive subpopulations express a higher amount of ITGA5, MMP2, MMP9, β-hCG, IGF2R 
and MMP15 than their syngeneic, HLA-G negative counterpart. The higher β-hCG secretion and IGF2R expression suggest the 
presence of an autocrine loop stimulating invasion. Furthermore, the strong effect of TNFα on the up-regulation of MMP15 
expression in HLA-G positive cells suggests modulation of trophoblast invasion and/or action by TNFα.Page 8 of 13
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an example a novel effect of TNF-α on MMP15 expression
in HLA-G positive first trimester trophoblasts and ACH-
3P was found (Figure 7).
Methods
Cell lines
The mutant choriocarcinoma cell line AC1-1 was derived
from JEG3 by mutagenesis and subsequent cloning of
mutants defective for hypoxanthin-guanin-phosphoribo-
syl-transferase .
Isolation of primary trophoblast cells from first trimester 
placenta
The study was approved by the Ethical Committee of the
Medical University of Graz.
Primary trophoblasts were isolated from first trimester
placentas (weeks 11 and 12, n = 12) after pregnancy ter-
minations for psychosocial reasons as described previ-
ously .
Briefly, chorionic villi were digested for 15 min at 37°C in
a digestion mix containing trypsin (0.125%, Gibco, Pais-
ley, UK) dispase/Ribonuclease A (2.4 U/ml dispase, Roche
Diagnostics, Mannheim, Germany; 0.013% Ribonuclease
A, Sigma Chemicals, St. Louis, USA). The dispersed cells
were separated from the residual tissue by filtration
through a cell sieve, and applied on top of a Percoll (Phar-
macia, Uppsala, Sweden) density gradient ranging from
10% (v/v) to 70%. After centrifugation, the band contain-
ing the trophoblasts was collected. Cells were further puri-
fied by incubation with immuno-magnetic beads
(Dynabeads M-450, Dynal) conjugated with CD45 RB
Leukocyte Common antigen (Dako, CA) and, subse-
quently, incubated with beads conjugated with the fibro-
blast-specific antibody A 502 (Dianova, Hamburg,
Germany). This procedure removes all non-trophoblastic
components . Primary trophoblasts were cultured in
DMEM (Gibco) supplemented with 10% FCS in a humi-
fied atmosphere of 5% CO2 at 37°C for 48 h. The cells
thus obtained represent a mixture of both trophoblast
subpopulations i.e., villous and extravillous trophoblasts.
Cell fusion
Immortal AC1-1 cells and primary trophoblast cells were
fused as described. Cells were detached by a 0.25% trypsin
solution, washed and equal numbers of AC1-1 cells and
trophoblasts were mixed and pelleted. One ml of a pre-
warmed solution containing 30% v/v polyethylene glycol
(Roth, Darmstadt, Germany) and 10% v/v dimethylsul-
foxide in Ham's F-12 (Gibco) was added drop wise over a
period of 1 min. This procedure was repeated twice. Sub-
sequently, 7 ml of Ham's F-12 was added, the resulting
cell suspension was pelleted and resuspended in Ham's F-
12 with 10% FCS. Every two passages, the cells were cul-
tured in selection medium containing azaserin (5.7 μM)
and hypoxanthine (100 μM).
Proliferation and size distribution
For the determination of the generation time i.e., the time
between two dividing steps of a single cell, AC1-1 and
ACH-3P cells were grown in 24 well plates with Ham's F-
12 medium supplemented with 10% FCS (HiClone).
After 12, 36 and 60 hours trypsinized cells were counted
using a CASY® Cell Counter (Schärfe System, Germany)
that concomitantly measures the cellular size distribution.
The experiment was run in triplicate.
Secretion of hCG
First trimester trophoblasts, ACH-3P and AC1-1 were
grown in their appropriate culture medium (DMEM and
Ham's F-12) supplemented with 10% FCS. The concentra-
tion of hCG was determined in the culture medium (Dade
Behring Inc., Deerfield, Illinois) after 24 and 48 hours
and normalized to the cell number at each time point.
Immunocytochemistry
Cells were grown on chamber slides until confluency and
then fixed with ice-cold acetone (Merck, Darmstadt, Ger-
many) for 5 min. The presence of cytokeratin-7 (Clone
OV-TL 12/30; 1:200; Dako) and vimentin (Clone V9;
1:500; Dako) was detected by the antiperoxidase method
(Lab vision, Fremont, CA). Slides were washed in TBS (tris
buffered saline) pH 7.5 with 0.05% Tween 20 (Sigma, St.
Louis, MO) for 5 min. Non-specific binding sites were
blocked with UV block (Lab vision) for 10 min. Subse-
quently, the primary antibody (diluted in Dako antibody
diluent) was applied for 30 min. After three washings in
TBS/Tween the secondary antibody (goat anti polyvalent,
Lab vision) was applied for 10 min. Following further
washings, the slides were incubated with streptavidin per-
oxidase (Lab vision) for 10 min and washed again. The
chromogenic reaction was started by addition of AEC sub-
strate system (Lab vision) for 4 min and washing in aqua
dest. Haemalaun (Sigma) solution was used for nuclear
counterstaining. Slides incubated with mouse unspecific
immunoglobulin fractions (Mouse IgG1 negative control,
Dako) in the same concentration as the primary antibody
served as negative controls.
Analysis by flow cytometry
a) Staining of cells
ACH-3P and AC1-1 cells were trypsinized from subcon-
fluent cultures. Primary trophoblast cells were trypsinized
from adherent cultures 24 hours after isolation. Cells were
centrifuged for 5 min at 3000 rpm and 20°C, washed in
washing buffer phosphate-buffered saline (PBS) with
0.25% bovine serum albumin and 2 mM EDTA, divided
into portions of 1–4 × 105 cells each, and centrifugedPage 9 of 13
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the following antibodies were used: anti-integrin α1
(Clone FB12; 1:500; Chemicon), anti-integrin α6 (Clone
GoH3; 1:500; BD Pharmingen), anti-integrin β4 (BD
Pharmingen; 1:500), anti-integrin α5β1 (Dako; 1:25),
and HLA-G (Clone MEM-G/9; 1:500; Abcam). For stain-
ing of cytoplasmatic antigens (cytokeratin-7; 1:500 and
vimentin; 1:360) and DNA (with propidium iodide, PI)
cell pellets were first resuspended in 0.5 ml 70% metha-
nol in distilled water, -20°C, by repeatedly pipetting up
and down. Cells were methanol-fixed for 10 min at 4°C,
washed and centrifuged again. Cell pellets of live or meth-
anol-fixed cells were resuspended in 100 αl blocking
buffer (washing buffer with 5% FCS and 5% pooled
human serum) containing the diluted primary antibody
and incubated with agitation for 30 min at RT. Cells were
washed again in 0.5 ml washing buffer, followed by incu-
bation in 100 μl washing buffer containing the appropri-
ate secondary antibody (rabbit anti-mouse-FITC, 1:200;
goat anti-rat-Cy2, 1:25) for 30 min at RT with agitation.
After further washing and centrifugation, cells were resus-
pended in 0.4 ml washing buffer. Buffered formalin, pH
7.0, was added up to 1% to stained live cells. Methanol-
fixed cells were resuspended in washing buffer containing
10 μg/ml PI and stored without formalin.
b) FACS analysis
A FACScalibur (Beckton Dickinson, San Jose, CA, USA),
with an Argon laser (488 nm) was used. Amplifiers for for-
ward scatter (FSC) and sidescatter (SSC) were set such that
the majority of events fitted inside a linear FSC/SSC dot-
plot. FITC staining was measured in channel 1 (FL1, band-
pass 515–545 nm) with logarithmic amplification, DNA
staining by PI was measured in channel 3 (FL3, bandpass
>600 nm) with linear amplification. A total of 5000
events were acquired of each sample. Data were quantita-
tively analysed using CellQuest Pro software (Beckton
Dickinson), and with WinMDI software, version 2.8
(Joseph Trotter, Scripps Research Institute, La Jolla, CA,
USA) for producing plots for reproduction. The measured
events were gated in an FSC/SSC plot to exclude subcellu-
lar fragments which have very low FSC and SSC and cell
aggregates characterized by very high SSC. Also, cellular
fragments lacking a nucleus (PI-negative) were gated out
from methanol-fixed samples. Of each sample, the mean
FITC- fluorescence intensity was plotted. The relative anti-
gen expression level in a cell population was calculated by
dividing the mean fluorescence measured after staining
with a particular antibody by the mean fluorescence level
measured after staining with the appropriate control anti-
body (Table 5). Antigen expression levels were therefore
depicted as "fluorescence intensity relative to control".
When a cell sample displayed a heterogeneous antigen
expression profile, a positive and a negative population
was isolated in separate gates. The proportion of cells
expressing or lacking this antigen was calculated. Moreo-
ver the relative antigen expression levels for the positive
and negative population was calculated separately in flu-
orescence intensities relative to control.
Zymography
Gelatin zymography was used to measure the activity of
MMP2 and MMP9. One × 105 ACH-3P, AC1-1 and pri-
mary trophoblast cells were seeded in 12-well plates and
grown in their appropriate culture medium (Ham's F-12
for the cell lines and DMEM for the primary cells) without
FCS. After 24 and 48 h, the culture supernatant was col-
lected and protein concentration was determined using
the Bradford assay (Bio-Rad Laboratories). Two-fold con-
centrated sample buffer, 126 mmol/L Tris-HCl, 20% glyc-
erol, 4% SDS, 0.005% bromphenol blue, was added 1:1 to
the culture supernatants containing equal amounts of
protein before loading on the 10% polyacrylamide gels
supplemented with 1% gelatine (Invitrogen, Carlsbad,
CA). Electrophoresis, renaturing and development of the
gels were performed according to the manufacturer's
instructions (Invitrogen). The developed gels were stained
with 5% Coomassie blue solution and destained appro-
priately. The gels were photographed and the proteolytic
activity was determined by densitometric analysis using
the Alpha DigiDoc 1000 (Alpha Innotech, CA) software.
Invasion Assay
Cell invasion activity was measured by a standard inva-
sion assay [15] and expressed as invasion index. Matrigel,
mouse laminin, collagen I and IV, and fibronectin were
coated on inserts with 3 μm pores. Invasion chambers and
inserts were purchased from Becton Dickinson, Bedford,
MA. One × 106 cells of each cell type were plated with 5 ml
DMEM onto 25 cm2 tissue culture flasks and incubated
with 50 μCi [3H]-5-methyl-thymidine overnight to prela-
bel the cells. After this incubation period, the adherent
cells were washed twice with HBBS (Gibco) and removed
with trypsin-EDTA. Cells were centrifuged at 300 × g for 7
min and resuspended in DMEM with 10% FCS. Five × 104
cells/500 μl media were plated onto the upper side of the
membrane of each insert of the 24 well Invasion Chamber
Assays. One ml DMEM was placed into the lower cham-
ber. Cells were cultured in 4–8 parallel wells for 24 and 48
hours under 5% CO2/95% air atmosphere at 37°C. After
Table 5: Antibodies and their appropriate IgG controls used for 
FACS analysis.
Host Antigen IgG subclass Isotype control
mouse integrin α5β1 IgG3, κ mouse IgG3
mouse integrin β4 IgG1, λ mouse IgG1
rat integrin α6 IgG2a rat IgG2a
mouse integrin α1 IgG1 mouse IgG1
mouse HLA-G IgG1 mouse IgG1Page 10 of 13
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wells were removed and placed in separate vials. Trypsin-
EDTA 1× was added to the upper wells to remove cells on
the surface of the membrane. The removed cells were
pooled with the media of the upper well. The membrane
was carefully removed from the plastic and pooled with
the media of the lower well. Radioactive disintegrations in
the vials were counted in a scintillation counter (Beck-
man). The invasion index was calculated according to the
formula: invasion index = radioactivity in lower well/radi-
oactivity in (lower well + membranes + upper well) × 100.
Cytogenetic analysis
The cultured cells were cytogenetically analysed according
to the standard protocols. Chromosome banding was pro-
duced by means of the trypsin-Giemsa method.
Microarray analysis
RNA was isolated from three different first trimester tro-
phoblast preparations and two different passages of AC1-
1 and ACH-3P, respectively, using Trizole (MRC, Ohio)
followed by quality assessment using a Bioanalyzer (Agi-
lent, CA). Experimental procedures and data analysis set-
tings followed proposed standards. From 5 μg of RNA,
cDNA was synthesized (SuperScript double stranded
cDNA Synthesis Kit, Invitrogen, CA), in vitro transcribed
(RNA Transcript Labeling Kit, Enzo diagnostics,
Farmingdale, NY) and fragmented. To test the quality of
the cRNA it was hybridized against Test-3arrays (Affyme-
trix, CA). As these met the criteria (bioC, bioD and cre
were present, the 3'/5' ratio of the polyA controls was < 3)
the cRNAs were hybridized against Affymetrix HU133A-
chips. RNA preparation and hybridization was performed
according to the Affymetrix user manual. Raw data were
normalized globally and processed with Microarray Suite
(MAS 5.0, Affymetrix) and Data Mining Tool (DMT,
Affymetrix). The mean of the replicates was calculated and
differentially expressed genes between primary trophob-
lasts and ACH-3P as well as between primary trophoblasts
and AC1-1 were selected by the following criteria: fold
change ≥ 2 or ≤ -2, change p-value ≥ 0.992 or ≤ 0.008 and
at least one signal intensity (control or treatment) >100.
Annotations were obtained from NetAffx.
Functional classification
The 'Gene Ontology Mining Tool' was used to extract the
putative biological function of the GeneChip probe sets
contained within subclusters as defined by the 'Gene
Ontology Consortium' . The Gene Ontology Mining Tool
determines the probability that a particular category of
'biological process' is enriched in the individual subclus-
ters calculated using the Chi squared test. Biological Sig-
nificance was based on the chi-square value, which
indicates significant enrichment of a particular biological
process within a set of probe sets genes. Differentially
expressed genes selected as above were clustered hierarchi-
cally using the EpClust software.
Immuno-separation of HLA-G positive and negative cells
ACH-3P cells were enzymatically detached by accutase
(PAA Laboratories, Pasching, Austria) treatment and fil-
tered through a cell sieve in order to obtain a single cell
suspension. First trimester primary trophoblast cells were
separated immediately after the normal isolation proto-
col. Cells were separated by incubation with immuno-
magnetic beads (Dynabeads M-450) conjugated with anti
HLA-G antibody (MEM-G/9; Abcam). The unbound,
HLA-G negative, cells and the cells bound to the beads
were subsequently cultured in the appropriate medium.
The quality of separations was controlled by measuring
expression levels of HLA-G (mRNA).
Semi quantitative RT-PCR
Total RNA was isolated from the HLA-G positive and neg-
ative ACH-3P with Trizole. Primers (Table 2) were
designed using the public web-page Primer3  and pur-
chased from Ingenetix (Vienna, Austria). The primer-pairs
included splicing sites within the amplicon. The mRNA-
amount of the ribosomal protein L30 (RPL30) was used
as an internal control. 200 ng total RNA was used for the
one step RT-PCR kit from Quiagen (Hilden, Germany)
according to the manufacturer's instructions. The opti-
mum cycle number was determined for each primer-pair
(given in Table 2). The annealing temperature for all
primer pairs was 59°C. PCR-products were electro-
phoresed on 3% agarose gels, documented with the Eagle-
Eye™ system (Stratagene, CA) and quantified with the
AlphaDigiDoc 1000 (Alpha Innotech, CA) software.
TNF-α treatment of HLA-G positive and negative ACH-3P 
cells
One × 105 HLA-G positive and negative ACH-3P cells
(passage 2) were seeded into 12 well plates in DMEM
medium with 10% (v/v) FCS. After 24 h, cells were serum
starved for 4 h in DMEM without FCS followed by addi-
tion of 10 ng/ml human recombinant TNF-α (Sigma). No
TNF-α was added to the controls. Cells were cultured in
the presence of 20% oxygen for 48 hours at which time
RNA was isolated (Trizole) and expression of RPL30 and
MMP15 was measured by RT-PCR. The experiment was
performed in quadruplicates.
TNF-α treatment on first trimester explants
First trimester placenta tissue samples (week 7–8) were
rinsed in PBS and dissected into small pieces of approxi-
mately 10 mg moist mass. Placental villi were clamped on
small polystyrene floats and cultured in 12 well dishes
floating in DMEM/F12 (1:1, v/v) (F12, Sigma, Steinheim,
Germany) without FCS for 48 h. Explant cultures were
incubated in a hypoxy-bench (invivo2 1000, RuskinnPage 11 of 13
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O2 and 5% CO2. For TNF-α treatment the culture medium
was supplemented with 10 ng/ml TNF-α (Sigma). The
experiment was run in triplicates.
Statistical analysis
The results are presented as mean ± standard deviation.
After testing for normal distribution Student's t-test was
used to test for significant differences. P-values of less than
0.05 were accepted as statistically significant.
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